论文部分内容阅读
目的观察老年非瓣膜性心房颤动病例抗凝治疗临床效果,提高老年心房颤动患者存活率及生存质量。方法收集2009年5月至2011年5月住院的心房颤动患者(年龄≥65岁)。分析抗凝治疗方法和效果。结果共140例住院患者,平均随访8.4个月(7.0～14个月)。有效随访126例,其中包括年龄﹤75岁组66例和年龄≥75岁组60例。失访14例(10%)。随访期间16例(12.69%)死亡。本组32例(25.40%)进行了抗凝治疗。结论老年心房颤动患者进行抗凝病者尚少,达标率低。应该对老年心房颤动患者的抗凝治疗加以关注。
Objective To observe the clinical effects of anticoagulant therapy in elderly patients with non-valvular atrial fibrillation and to improve the survival rate and quality of life of elderly patients with atrial fibrillation. Methods Patients with atrial fibrillation (age ≥65 years) hospitalized from May 2009 to May 2011 were collected. Analysis of anticoagulant therapy methods and effects. Results A total of 140 inpatients were followed up for an average of 8.4 months (7.0-14 months). Effective follow-up of 126 cases, including 66 cases of age <75 years old and age> 75 years old group of 60 cases. Fourteen cases were lost (10%). 16 cases (12.69%) died during follow-up. The group of 32 patients (25.40%) were anticoagulant therapy. Conclusion Aged patients with atrial fibrillation are still less anticoagulation, low compliance rate. Anticoagulation should be noted in elderly patients with atrial fibrillation.